The IARS recently announced the appointment of Lena S. Sun, MD, as the Medical Director of SmartTots. Dr. Sun is an established basic science, translational and clinical researcher, a board-certified physician in Pediatrics, Anesthesiology and Pediatric Anesthesiology and a practicing pediatric anesthesiologist. As the Medical Director of SmartTots, she will help promote and advocate for research to advance and ensure safety of anesthesia in children. She will specifically work with researchers, clinicians, parents and other relevant stakeholders to develop future research strategies to address the pressing challenges to understand the effects of anesthetic and sedative agents in the developing brain. She will also work with all stakeholders to support the implementation and dissemination of research results related to all SmartTots-related issues.
- Prenatal Exposure to General Anesthesia and Childhood Behavioral Deficit
- Increasing the interval between repeated anesthetic exposures reduces long‐lasting synaptic changes in late post‐natal mice
- Tau Contributes to Sevoflurane-induced Neurocognitive Impairment in Neonatal Mice
- Neonatal exposure to sevoflurane expands the window of vulnerability to adverse effects of subsequent exposure to sevoflurane and alters hippocampal morphology via decitabine-sensitive mechanisms
- Sevoflurane Post-Conditioning Ameliorates Neuronal Deficits and Axon Demyelination After Neonatal Hypoxic Ischemic Brain Injury: Role of Microglia/Macrophage